Back to News
Market Impact: 0.25

GEO Shares Down 44% as Fund Sells $9 Million in Stock Amid ICE Allegations and Softer Outlook

GEO
Company FundamentalsCorporate Guidance & OutlookCorporate EarningsLegal & LitigationInvestor Sentiment & PositioningMarket Technicals & Flows
GEO Shares Down 44% as Fund Sells $9 Million in Stock Amid ICE Allegations and Softer Outlook

Apis Capital Advisors trimmed its stake in GEO Group by selling 394,000 shares in Q3 (estimated $9.0M based on quarterly average pricing), leaving a 860,000-share position valued at $17.6M and representing 3.9% of its 13F-reportable AUM, removing GEO from the fund’s top-five holdings. GEO shares trade at $15.58 (down 44% year-over-year) with a $2.2B market cap; company TTM revenue is $2.5B and net income $238.1M, but management issued softer Q4 guidance (GAAP EPS $0.23–$0.27 on $651M–$676M revenue) and recorded a $37.7M reserve for detainee claims, leaving litigation and tightened guidance as near-term negative catalysts despite recent contract wins and better-than-expected Q3 results.

Analysis

Market structure: Apis’ ~394k-share, ~$9m trim is a sentiment signal more than a liquidity shock—float impact <1% of GEO’s ~$2.2B market cap—but it increases the risk of follow-on selling from concentrated managers reallocating out of a risky, litigated name. Direct beneficiaries are alternative providers of detention-related services (CoreCivic/CXW) and electronic-monitoring vendors if GEO loses contracts; losers are GEO equity and subordinated creditors if legal/regulatory outcomes worsen. Options IV should remain elevated near earnings/legal events and credit spreads can gap wider on adverse news (>100–200bps move plausible). Risk assessment: Tail risks include a large litigation judgment or settlement >$200m, a federal policy shift away from private detention that removes ICE demand, or sudden contract terminations; any of these could halve equity value within months. Near-term (days–weeks) risk is event-driven volatility around 13F headlines and the upcoming Q4 print; short/medium term (3–12 months) depends on Q4 guidance, litigation filings, and 2026 contract ramp. Hidden dependency: revenue upside hinges on federal immigration policy and ICE bed utilization, not just contract wins. Key catalysts: Q4 earnings (30–60 days), court rulings on detainee claims (variable), and FY-2026 contract execution timelines. Trade implications: Tactical bearish exposure via limited-risk put spreads (e.g., buy Feb-26 $12 / sell $8) sized to 1–3% NAV captures event risk while capping cost; alternatively, establish a conditional value long of 2–3% NAV if shares drop below $12 and no material increase in litigation reserves within 90 days. Relative-value: long CXW (CoreCivic) vs short GEO (equal notional 1–2% NAV each) for 6–12 months if you expect market to concentrate on better-positioned operators. Rotate 50% of sector weight into defense/security names (e.g., LHX, RTX) over 30 days to reduce regulatory concentration. Contrarian angles: The market may be over-pricing legal and policy risk versus current earnings — GEO trades near a P/E ~9 (TTM net income $238M vs $2.2B cap), implying a deep-value floor if contracts stay intact and reserves remain modest ($37.7M now). That said, consensus often understates policy binary risk; a small, disciplined long could pay off if 2026 ICE beds and transport revenues ramp as guided. Historical parallels: regulatory scares in outsourced public services produced 30–100% recoveries once legal clarity emerged, but they required 6–18 months and active management to realize gains.